ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.24
0.16%
Dow Jones
39,499.75
0.28%
US Dollar vs MXN
16.78822
-0.04%
Brent Oil
82.715
-1.47%
Bitcoin
60,802.40
-3.56%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Alcon Inc (ALC)

  7. Alcon Inc (ALC) Noticias

ALC

Alcon (ALC)

Alcon Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:ALC
FechaHoraFuenteTítuloSímboloCompañía
08/05/202415:30Business WireAlcon Announces Results of 2024 Annual General MeetingNYSE:ALCAlcon Inc
01/05/202408:45Business WireAlgoma Central Corporation Reports Financial Results for the 2024 First QuarterNYSE:ALCAlcon Inc
07/04/202416:59Business WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
12/03/202403:30Business WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
06/03/202408:55Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
06/03/202408:55Business WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
01/03/202417:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
27/02/202415:30Business WireAlcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023NYSE:ALCAlcon Inc
26/02/202406:00Business WireAlgoma Central Corporation Reports Financial Results for Fiscal 2023NYSE:ALCAlcon Inc
12/02/202415:22Business WireAlgoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024NYSE:ALCAlcon Inc
01/02/202412:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ALCAlcon Inc
01/02/202408:02Business WireAlcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytieNYSE:ALCAlcon Inc
18/01/202407:54Business WireAlgoma Central Corporation continues to grow product tanker business with the acquisition of two additional vesselsNYSE:ALCAlcon Inc
10/01/202403:12Dow Jones NewsAlcon Shares Rise After Dry-Eye Care Drug Shows Promising ResultsNYSE:ALCAlcon Inc
09/01/202416:20Dow Jones NewsAlcon Reports Results for Dry-Eye-Treatment TrialsNYSE:ALCAlcon Inc
09/01/202415:30Business WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
05/01/202407:00GlobeNewswire Inc.Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial ArrangementsNYSE:ALCAlcon Inc
27/12/202308:01Business WireAlcon to Present at 2024 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
15/11/202310:08Dow Jones NewsAlcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:ALCAlcon Inc
15/11/202305:11Dow Jones NewsAlcon's Swiss Shares Drop After Guidance Narrowed to Lower End of RangeNYSE:ALCAlcon Inc
14/11/202315:30Business WireAlcon Reports Third Quarter 2023 ResultsNYSE:ALCAlcon Inc
08/11/202308:03Business WireAlcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytieNYSE:ALCAlcon Inc
03/11/202314:00Business WireAlgoma Central Corporation Reports Financial Performance for the 2023 Third QuarterNYSE:ALCAlcon Inc
30/10/202308:01Business WireAlcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023NYSE:ALCAlcon Inc
27/10/202306:00Business WireAlgoma Central Corporation to Issue Third Quarter 2023 Financial Results on November 3, 2023NYSE:ALCAlcon Inc
10/10/202307:01Business WireAlcon Launches TOTAL30 Multifocal Contact Lenses for Patients with PresbyopiaNYSE:ALCAlcon Inc
14/09/202306:00Business WireAlgoma Central Corporation and Furetank Co-Order Two Additional NewbuildsNYSE:ALCAlcon Inc
09/09/202300:01Business WireCataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle DependenceNYSE:ALCAlcon Inc
06/09/202315:30Business WireAlcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical TeamsNYSE:ALCAlcon Inc
15/08/202315:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
 Showing the most relevant articles for your search:NYSE:ALC

Su Consulta Reciente

COIN
DJVUSD
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados